[ Allurion Technologies raises $27M in Series C funding ]
Allurion Technologies has raised $27 million in Series C funding.
Founded in 2009, Allurion Technologies develops a medical device for weight loss that can be delivered and removed without surgery or endoscopy.
The funding will support the company’s FDA pivotal study, which will start next year; build the sales and marketing team to increase sales outside the U.S. and improve manufacturing.
|Founder / CEO||Jonathan Wecker|
|Previous Investors||Romulus Capital|